Financial Statements Statement of Cash Flows For the year ended 31 December 2018 2018 2017 Notes US$000 US$000 OPERATING ACTIVITIES Profit for the year before tax 9 50,719 23,425 Adjustments for: Share based payments 12 9,704 9,181 Dividend Income 71,221 44,385 10,798 11,779 Working capital changes: Amounts due from a related party 11,705 Other receivables and prepayments 48 18 Amounts due to a related party 10,388 Other payables and accruals 418 2 Net cash used in operations 40 58 DECREASE IN CASH AND CASH EQUIVALENTS 40 58 Cash and cash equivalents at 1 January 162 220 CASH AND CASH EQUIVALENTS AT 31 DECEMBER 122 162 Note: 1 Proceeds of US$139,191,000 raised from issuance of equity were directly received in NMC Healthcare LLC bank account.
For the purpose of statement of cash flows these proceeds are adjusted from amounts due from a related party.
2 An amount of US$138,538,000 was paid by NMC Healthcare LLC, on behalf of the Company for acquisition of subsidiaries.
3 During the year the Company recorded dividend income of US$ 71,221,000.
This was non cash transactions and adjusted from amount due from related party.
4 Dividend amount of US$ 35,739,000 was paid by NMC Healthcare LLC on behalf of the Company to its shareholders.
This is non cash transactions and adjusted from amount due from related party.
The attached notes 1 to 16 form part of the financial statements.
160 NMC Health plc Annual Report and Accounts 2018
